Page 172 - ASHG 2013 Program Guide

POSTER SESSIONS
  159
POSTER SESSIONS
W=W
ednesday authors will present; T=Thursday authors will present; F=Friday authors will pr
esent
1100
F Whole genome sequencing identifies novel low
frequency variant associations in liver function traits.
L. Quaye, on behalf of UK10K Consortium Cohorts Group.
1101
W Autozygosity mapping in Pakistani intellectual
disability families.
M. Rafiq, K. Mittal, I. A. Balouch, A.
Noor, C. Windpassinger, A. Mikhailov, M. Aslam, M. Ayaz,
A. Mir, M. Ansar, P. John, M. Ayub, J. B. Vincent.
1102
T Identifying genetic variants associated with
anorexia nervosa via exome sequencing.
S. Yu, E.
Pruett, R. Cone, B. Li.
1103
F Identifying the genetic architecture of neural
tube defects by exome sequencing a multiplex
anencephaly family.
K. Soldano, D. Krupp, H. Cope, M.
Garrett, A. Ashley-Koch, S. Gregory.
1104
W Whole exome sequencing case-control using
1,000
severe obesity cases identifies putative new loci
and replicates previously established loci.
A. Hendricks,
on behalf of UK10K Consortium: Obesity.
1105
T Rare variant association analysis reveals novel
associations with lipids in genes within established
loci via imputation up to the 1000 Genomes Project
reference panel.
R. Magi, M. Horikoshi, I. Surakka, S.
Wiltshire, A.-P. Sarin, T. Esko, A. Mahajan, T. Ferreira,
M. Beekman, S. Gustafsson, S. Hägg, C. I. Ladenval,
L. Marullo, C. P. Nelson, J. S. Ried, G. Thorleifsson,
N. Tsernikova, S. M. Willems, C. Willenborg, T. Winkler,
C. M. Lindgren, M. I. McCarthy, S. Ripatti, I. Prokopenko,
A. P. Morris, ENGAGE Consortium.
1106
F Identification of common and ra e variants
associated with trunk fat mass using whole-genome
sequencing in the UK10K project.
L. Paternoster, UK10K
Consortium Cohorts Group.
1107
W Statistical dissection of genetic factors
influencing antibodies against Epstein-Barr virus
nuclear antigen 1 using whole-genome sequence
data.
R. Rubicz, M. Almeida, E. Drigalenko, T. D. Dyer,
T. M. Teslovich, G. Jun, J. M. Peralta, C. Fuchsberger,
A. R. Wood, A. R. Manning, T. M. Frayling, P. Cingolani,
R. Sladek, D. M. Lehman, J. W. Kent Jr., J. B. Harley,
M. A. Carless, J. E. Curran, M. P. Johnson, S. A. Cole, L.
Almasy, E. Kraig, G. Abecasis, R. Yolken, R. Duggirala,
C. T. Leach, J. Blangero, H. H. H. Göring, T2D-GENES
Consortium.
1108
T Whole exome sequencing in age-related
macular degeneration.
P. Whitehead, W. K. Scott, G.
Wang, W. Cade, M. D. Courtenay, S. G. Schwartz, J. L.
Kovach, A. Agarwal, J. L. Haines, M. A. Pericak-Vance.
1109
F Whole genome sequencing association study for
quantitative ultrasound of the calcaneus.
S. G. Wilson,
on behalf of UK10K Cohorts.
1110
W Targeted sequencing, augmented with public
resources, identifies a ra e C3 allele associated with
large risk of age-related macular degeneration.
X.
Zhan, D. Larson, R. Fulton, C. Wang, D. Stambolian, E.
Chew, E. Mardis, A. Swaroop, G. Abecasis.
1089
W Whole-genome sequencing of individuals
from a founder population identifies candidate genes
for asthma.
C. D. Campbell, K. Mohajeri, M. Malig, F.
Hormozdiari, B. Nelson, G. Du, K. Patterson, C. Eng, D. G.
Torgerson, J. X. Chong, A. Ko, L. Vives, B. J. O’Roak, M.
Abney, E. G. Burchard, C. Ober, E. E. Eichler.
1090
T Cluster detection approaches to identify disease
genes in CNVs implicated in psychiatric disorders:
Applications to whole exome sequencing studies on
autism and schizophrenia.
I. Ionita-Laza, B. Xu, V. Makarov,
J. Buxbaum, J. Louw Roos, J. Gogos, M. Karayiorgou.
1091
F Identification and characterization of the firs
OSBPL1A
mutations in individuals with low plasma
HDL-C levels.
M. M. Motazacker, H. Kentala, J. A.
Kuivenhoven, A. W. Schimmel, Y. Zhou, J. Pirhonen, E.
Ikonen, G. M. Dallinga-Thie, G. K. Hovingh, M. Jauhiainen,
V. M. Olkkonen.
1092
W Whole exome sequencing to identify variants
influencing both p e-diabetic traits and type 2 diabetes
mellitus in Pima Indians.
L. J. Baier, K. Huang, A. Nair, Y.
L. Muller, M. del Rosario, S. Kobes, R. L. Hanson, W. C.
Knowler, C. Bogardus.
1093
T Whole exome sequencing of 4,000 samples
identifies ra e variants strongly associated with type 2
diabetes risk in Mexicans and Latinos.
K. Estrada, for
the SIGMA T2D Consortium.
1094
F A test of association of genome-wide coding
variation with type 2 diabetes in 13,000 individuals from
five ancestry groups.
P. Fontanillas, N. Burtt, P. Cingolani,
J. Flannick, K. Gaulton, H. Highland, A. Mahajan, A.
Morris, M. Rivas, X. Sim, T. Teslovich, on behalf of T2D-
GENES and GoT2D Consortia.
1095
W Whole genome sequencing to identify variants
that influence p e-diabetic traits in American Indians.
K. Huang, P. Piaggi, S. Kobes, R. Hanson, C. Bogardus,
L. Baier.
1096
T Whole exome sequencing identifies
PAX4
nonsynonymous variant as susceptibility loci for type 2
diabetes in Koreans.
S. H. Kwak, J. I. Kim, K. Kim, Y. M.
Cho, H. S. Jung, Y. J. Park, K. S. Park.
1097
F Large-scale exome chip association analysis
identifies ra e and low-frequency coding variants
associated with glycemic traits.
A. Mahajan, X. Sim, A. K.
Manning, M. A. Rivas, N. Grarup, H. K. Im, H. M. Highland,
A. E. Locke, P. Fontanillas, T. M. Teslovich, J. Flannick, C.
Fuchsberger, K. Gaulton, H. M. Kang, A. P. Morris, J. B. Meigs,
C. M. Lindgren, for T2D-GENES and GoT2D Consortia.
1098
W Exome Chip genotyping in 9,000 individuals
(
type 2 diabetes and controls) in Mexican and Latinos.
J. M. Mercader, H. Moreno, A. Huerta, M. J. Gomez, for
SIGMA T2D Genetics Consortium.
1099
T A low frequency coding variant (A316T) in the
glucagon-like protein receptor 1 is associated with fasting
glucose levels.
D. Waterworth, R. Scott, L. Li, C. Gillson, J.
Aponte, L. Warren, S. Chissoe, M. Ehm, N. Wareham.